Latest article
Returning to health routines means going again to fundamentals
EUGENE, Ore. If you are planning on getting back to the gym because many Oregon counties have capacity restrictions, experts say you should...
Lilly’s tirzepatide beats Ozempic in head-to-head kind 2 diabetes trial
Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...
Frailty upsets danger–profit steadiness of intensive sort 2 diabetes therapy
medwireNews: Researchers find a reduced cardiovascular gain and an increased risk of...